Тема: Вибуркол
Показать сообщение отдельно
  #13  
Старый 17.07.2011, 15:33
Lobanoff Lobanoff вне форума ВРАЧ
Врач-участник форума
 
Регистрация: 11.04.2011
Город: Иркутск
Сообщений: 3
Lobanoff *
Цитата:
Сообщение от easl Посмотреть сообщение
Да-да! Чем здоровее гeликобактер и хламидия, тем больше финансовых вложений!
Или вы о другом?
Если будет референдум по геликобактеру, буду голосовать за включение его в группу ООИ, и как инфекционистов с этим пройдохой обошли?
Посмотрел резюме по обзору исследований в гомотоксикологии.
J Clin Pharmacol. 2004 Jul;60(5):299-306. Epub 2004 Jun 9.
Homotoxicology--a review of randomised clinical trials.
Ernst E, Schmidt K.
Source
Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth, 25 Victoria Park Road, Exeter EX2 4NT, UK. [Ссылки доступны только зарегистрированным пользователям ]
Abstract
AIM:
Homotoxicology is a form of therapy that uses homoeopathically diluted remedies with a view of eliminating toxins from the body. It is not a therapeutic method based on accepted scientific principles or biological plausibility. Yet numerous clinical studies have claimed efficacy. The aim of this systematic review is to summarise and critically evaluate the evidence from rigorous clinical trials of this form of therapy.
METHODS:
Seven electronic databases were searched for all studies of homotoxicological medicines for any human condition. To be included, trials had to be randomised and placebo-controlled. Data from such studies were validated and extracted according to pre-defined criteria. Their methodological quality was formally assessed using the Jadad score. Key data of all included trials were tabulated and summarised in narrative form.
RESULTS:
Seven trials met our inclusion criteria. Their Jadad scores indicated mostly a high methodological standard. The trials tested the efficacy of seven different medicines for seven different indications. The results were positive in all but one study. Important flaws were found in all trials. These render the results of the primary studies less reliable than their high Jadad scores might suggest.
CONCLUSION:
Despite mostly positive findings and high ratings on the Jadad score, the placebo-controlled, randomised clinical trials of homotoxicology fail to demonstrate the efficacy of this therapeutic approach.
[Ссылки доступны только зарегистрированным пользователям ]
Результаты не утешительны.
Вот почти совсем свежее исследование.
Altern Ther Health Med. 2010 Jan-Feb;16(1):54-9.
A series of case reports: clinical evaluation of a complex homeopathic injection therapy in the management of pain in patients after breast cancer treatment.
Orellana Alvarellos G, Ruiz de Viñaspre Alvear P, Kaszkin-Bettag M.
Source
Center of Obstetrics and Gynecology, Ginesia SA, Providencia, Santiago de Chile, Chile.
Abstract
OBJECTIVE:
In breast cancer patients, posttreatment pain often appears after several months and strongly impairs health-related quality of life. Conventional methods of pain reduction are often ineffective. Injection therapy with Traumeel (Heel GmbH, Baden-Baden, Germany), a medication with analgesic properties used in homotoxicology for treatment of the pain associated with trauma as well as a mediator of inflammation, was proposed as an innovative approach for pain relief after breast cancer treatment.
DESIGN:
Nine patients, still suffering from a high level of pain after breast cancer therapy despite use of postoperative treatment with conventional analgesics, were invited to participate. A Traumeel and procaine injection was administered once a week for three to 10 sessions. The level of pain was assessed by a pain score and physical and psychological status by a questionnaire before and directly after injection and again at follow-up visits after 3 and 6 months.
RESULTS:
After the last injection, all patients experienced a marked reduction of their level of pain on average from 7.6 +/- 1.5 to 2.4 +/- 1.4 points on a scale from 1 to 10 points. After a followup observational phase of 3 and 6 months, pain score ratings increased slightly again in some patients but remained consistently low in others. In any case, the ratings of pain levels did not reach the values assessed before the start of Traumeel injection. Similarly, health-related quality of life improved with this injection therapy. The perception of pain relief with Traumeel injection was high in 8 of 9 patients, reflecting an overall perceived positive outcome and tolerability of this treatment.
CONCLUSIONS:
This case series represents a first encouraging approach to using this complex homeopathic injection for pain relief in breast cancer patients.
[Ссылки доступны только зарегистрированным пользователям ]
Вроде эффективность доказана, но крайне мала группа наблюдения.
Обнаружил закономерность, есть статьи с интересными и многообещающими результатами, но их нет в открытом доступе.
Ответить с цитированием